Company intelligence / Profile preview

RoukenBio

Glasgow, Scotland, United Kingdomleadiq.com ↗

Ownership: Private
Development stage: Preclinical

Overview

RoukenBio is an innovative immunology-focused CRO providing bespoke in vitro drug discovery and development services. They specialize in advanced assay platforms, custom cell-based models, and support for a broad spectrum of therapeutic modalities from early research through IND-enabling studies. Their expertise spans inflammation, auto-immunity, immuno-oncology, and oncology. They are recognized for their collaborative approach and high client satisfaction.

Therapeutic areas: OncologyImmunology
Modalities: Small moleculeLarge moleculeMonoclonal antibodyAntibody-drug conjugateCell therapyNanoparticleProtein degrader therapyPeptidesRecombinant proteinVaccine
Industry: Drug Discovery Services

Partnerships

Not specifically listed; works with global biotherapeutic innovators as clients/partners

Beyond the preview

Go deeper on RoukenBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RoukenBio.

Explore the full profile